Geel, Belgium
Genzyme Corp. initiated construction in January of 2011 on a $344 million pharmaceutical manufacturing plant in Geel, Belgium. The facility will provide 8,000 liters of production capacity for biologics and a complete purification installation. Completion is expected in late 2014. Genzyme is based in Cambridge, Mass.
